Zimbabwe has rejected a significant American health deal worth 367 million US dollars (£272m) spanning five years because of the United States' insistence on sensitive information.
The decision became public after a official document from December was disclosed, which showed President Emmerson Mnangagwa felt the agreement was "skewed".
An official representative later stated that the United States was seeking biological samples for research and commercial purposes but was unwilling to guarantee the benefits from any future vaccines.
"We will now turn to the challenging and unfortunate task of scaling back our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged continued dialogue to reach a agreement agreeable to both sides so the country's vital HIV treatment initiative can be sustained.
Broader Background
This development follows a comparable case in Kenya, where a high court suspended a similar health funding agreement following legal challenges were raised about the security of citizens' health data.
After resuming office last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
The agency had overseen aid for the American government, but Trump argued its expenditure was "wasteful" and his administration was pursuing direct bilateral deals to boost openness and accountability.
According to statements, Sixteen nations in Africa have to date signed these new agreements, representing over $18.3bn in committed funds.
Specifics of the Declined Agreement
This assistance for Zimbabwe was intended to gone towards "tackling HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We believe this collaboration might have yielded immense benefits for Zimbabwean communities, especially the 1.2 million men, women and children currently receiving HIV treatment via American-funded programmes," the Ambassador said.
However, government spokesperson Nick Mangwana said the arrangement was "unfair".
"Our nation was requested to provide its biological resources and data indefinitely, with no equivalent assurance of access to any medical innovations – like vaccines, diagnostics, or treatments – that might result from that shared data," he stated.
"Put simply, our nation would provide the raw materials for scientific discovery with no assurance that the end products would be accessible to our people should a future pandemic emerge."
Sovereignty and International Frameworks
Mangwana further pointed out that the American exit from the World Health Organization (WHO) and its push of bilateral health agreements were undermining frameworks already established through the international health agency.
The spokesperson cited its Pathogen Access and Benefit Sharing framework designed to deal with potential global health emergencies.
"This framework is intended to ensure that when a country contributes its samples, the benefits – such as medicines and cures – are distributed fairly, not monopolised solely by those with the funds to create them."
The government's concerns regarding the US deal "should not be misconstrued as opposition to America," he added.
"We welcome further discussions with our American counterparts on how future collaboration could be arranged in a way that honours the sovereignty and interests of each country."
Medical Community Reaction
A leading public health body expressed it recognised the official position, but recommended that talks must proceed given that much of the nation's Aids initiatives depended on international support.
"Where specific concerns exist, such as those involving data governance or implementation frameworks, these can frequently be resolved via detailed discussion and negotiated safeguards," it commented.
This impasse highlights the complex debate between receiving vital international aid and safeguarding national sovereignty in an increasingly interconnected world.